<DOC>
	<DOC>NCT00333281</DOC>
	<brief_summary>This is a multicenter, randomized, double-blind, placebo-controlled study to evaluate the effects on vision of six months of daily dosing of 5 mg tadalafil or 50 mg sildenafil compared with placebo.</brief_summary>
	<brief_title>A Study of Visual Effects of Erectile Dysfunction Medications Dosed Daily for Six Months</brief_title>
	<detailed_description />
	<mesh_term>Erectile Dysfunction</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>Healthy male subjects or males with mild erectile dysfunction (ED). Between the ages of 30 and 65 years, inclusive. Phosphodiesterase type 5 (PDE5) inhibitor therapy (tadalafil, sildenafil, or vardenafil) within 6 weeks of the start of the study. Diagnosis of diabetes mellitus. Any chronic illness or medication that is a risk factor for eye disease or any medication that causes retinal toxicity or affects visual function. Certain chronic medical conditions including unstable angina pectoris, severe renal [kidney] insufficiency, clinically significant hepatobiliary [liver, bile duct] disease, cancer, and AIDS/HIV. A history of clinically significant chronic ophthalmologic disease or any significant visual abnormality identified at the start of the study.</criteria>
	<gender>Male</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Healthy Volunteers</keyword>
</DOC>